Showing 13 posts of 13 posts found.

PharmAla receives MDMA research grant from Ontario Centre of Innovation

June 12, 2023
Research and Development MDMA, PharmAla, Psychiatry, in silico, research grant

Canadian biotechnology company PharmAla has announced that it has been awarded a research grant from the Ontario Centre of Innovation …


Brain imaging biomarker could predict how psychiatric disorder patients respond to treatment

October 21, 2020
Research and Development MDMA, PTSD

A recent study has indicated that a newly identified brain imaging biomarker could help match patients with psychiatric disorders with …


First clinical trial for MDMA and LSD combination set to go ahead

August 28, 2020
Medical Communications LSD, MDMA, PTSD

Researchers are set to investigate a combined dose of LSD and MDMA to treat patients undergoing psychotherapy. The Phase 1 …


Study finds that MDMA has long-term benefits for treating PTSD

June 11, 2020
Business Services MDMA, PTSD

PTSD patients being treated with MDMA experience numerous beneficial effects that hold strong for well after a year after completing …


FDA advises recall of diabetes drug metformin over carcinogen concerns

May 29, 2020
Medical Communications Carcinogens, MDMA

The FDA has asked that multiple pharmaceutical companies recall the formulations of their diabetes drug metformin after the regulatory body …


FDA puts MDMA therapy for PTSD on its Expanded Access program

January 24, 2020
Medical Communications Expanded Access, MAPS, MDMA, PTSD, pharmaceuticals, psychedelics, war

The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …


FDA investigating if carcinogen NDMA is in diabetes drug

December 6, 2019
Medical Communications FDA, Health Canada, MDMA, NDMA, carcinogen, diabetes

The FDA is looking into if the diabetes drug metformin has unsafe levels of a cancer-causing chemical. This comes after …


Patients to recieve MDMA-assisted psychotherapy on ‘compassionate’ grounds in Israel

February 28, 2019
Research and Development MDMA, PTSD, drugs, mental health, psychedelics

The Israeli Health Ministry has approved the compassionate use of MDMA-assisted psychotherapy for 50 patients with post-traumatic stress disorder (PTSD). …


Psychedelic therapy: A new approach to mental health

December 10, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LSD, MDMA, controlled substances, depression, mental health, pharma, psychotherapy

In November 2018, a Phase 2 clinical trial found that 76% of patients who underwent MDMA-assisted psychotherapy no longer had …


76% of patients no longer experience PTSD a year after MDMA-assisted psychotherapy

November 6, 2018
Manufacturing and Production, Research and Development MDMA, PTSD, mental health, psychotherapy, research

Promising phase II results suggest that MDMA-assisted psychotherapy may be an “innovative, efficacious treatment for posttraumatic stress disorder,” according to …


Recreational drug MDMA proves efficacy in reducing PTSD symptoms, new study finds

May 3, 2018
Research and Development MDMA, PTSD, pharma

Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).


FDA fast-tracks recreational drug MDMA for treatment of PTSD

August 30, 2017
Research and Development, Sales and Marketing FDA, MDMA, PTSD, life sciences, pharma, pharmaceuticals

In another leap forward for the promising treatment, the FDA has announced that it has granted Breakthrough Therapy Designation to …


MDMA trials get FDA backing for PTSD treatment

November 30, 2016
Research and Development FDA, MDMA, PTSD

The FDA have given the go-ahead to Phase 3 clinical trials investigating the efficacy of MDMA (Methylenedioxymethamphetamine) for treating post-traumatic …

Latest content